Change in Nutrient and Dietary Intake in European Children with Cystic Fibrosis after a 6-Month Intervention with a Self-Management mHealth Tool.
cystic fibrosis
diet
dietary habits
food groups
m-health
nutrients
nutrition
self-management
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
26 May 2021
26 May 2021
Historique:
received:
30
03
2021
revised:
22
04
2021
accepted:
22
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
11
8
2021
Statut:
epublish
Résumé
Cystic Fibrosis (CF) is a life-long genetic disease, causing increased energy needs and a healthy diet with a specific nutrient distribution. Nutritional status is an indicator of disease prognosis and survival. This study aimed at assessing the effectiveness of a self-management mobile app in supporting patients with CF to achieve the dietary goals set by the CF nutrition guidelines. A clinical trial was conducted in pancreatic insufficient children with CF, followed in six European CF centres, where the self-management app developed within the MyCyFAPP project was used for six months. To assess secondary outcomes, three-day food records were compiled in the app at baseline and after 3 and 6 months of use. Eighty-four subjects (mean 7.8 years old) were enrolled. Compared to baseline, macronutrient distribution better approximated the guidelines, with protein and lipid increasing by 1.0 and 2.1% of the total energy intake, respectively, by the end of the study. Consequently, carbohydrate intake of the total energy intake decreased significantly (-2.9%), along with simple carbohydrate intake (-2.4%). Regarding food groups, a decrease in ultra-processed foods was documented, with a concomitant increase in meat and dairy. The use of a self-management mobile app to self-monitor dietary intake could become a useful tool to achieve adherence to guideline recommendations, if validated during a longer period of time or against a control group.
Identifiants
pubmed: 34073260
pii: nu13061801
doi: 10.3390/nu13061801
pmc: PMC8229611
pii:
doi:
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Horizon 2020 Framework Programme
ID : 643806
Références
J Acad Nutr Diet. 2019 Aug;119(8):1305-1319
pubmed: 30862484
BMJ Open. 2017 Mar 16;7(3):e014931
pubmed: 28302638
J Cyst Fibros. 2018 Nov;17(6):804-810
pubmed: 29724576
J Cyst Fibros. 2002 Jun;1(2):51-75
pubmed: 15463811
J Clin Epidemiol. 1988;41(6):583-91
pubmed: 3260274
Expert Opin Emerg Drugs. 2014 Mar;19(1):143-55
pubmed: 24479826
J Cyst Fibros. 2020 Jul;19(4):562-568
pubmed: 32335023
Am J Hypertens. 2017 Apr 1;30(4):358-366
pubmed: 27927627
Dig Liver Dis. 2014 Oct;46(10):865-74
pubmed: 25053610
Science. 2003 Feb 7;299(5608):853-5
pubmed: 12574618
Clin Nutr. 2014 Jun;33(3):528-32
pubmed: 23920501
JMIR Mhealth Uhealth. 2020 Jul 8;8(7):e15896
pubmed: 32673237
J Am Diet Assoc. 2008 May;108(5):847-52
pubmed: 18442509
J Cyst Fibros. 2013 Mar;12(2):102-15
pubmed: 23232324
J Pediatr Gastroenterol Nutr. 2015 Sep;61(3):355-60
pubmed: 25782658
J Cyst Fibros. 2020 Dec 2;:
pubmed: 33279468
Eur J Nutr. 2020 Apr;59(3):979-989
pubmed: 30949765
Nutr Metab Cardiovasc Dis. 2019 Jun;29(6):544-560
pubmed: 31078365
J Pediatr. 2013 Mar;162(3):530-535.e1
pubmed: 23062247
PLoS One. 2019 Feb 22;14(2):e0212459
pubmed: 30794618
Arch Pediatr Adolesc Med. 2009 Oct;163(10):915-21
pubmed: 19805710
Clin Nutr. 2016 Jun;35(3):557-77
pubmed: 27068495